Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3021% above fair value
$350.56−6.38 (-1.79%)
Close on Nov 17, 2026Market cap $66.90BP/E 26.0Yield 0.63%
Cencora r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Cencora
Cencora has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?